Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP322772.RABJntw9hkXc8B26gC38kTf4tzPJbYOC6gDAYSihggbN4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP322772.RABJntw9hkXc8B26gC38kTf4tzPJbYOC6gDAYSihggbN4130_assertion type Assertion NP322772.RABJntw9hkXc8B26gC38kTf4tzPJbYOC6gDAYSihggbN4130_head.
- NP322772.RABJntw9hkXc8B26gC38kTf4tzPJbYOC6gDAYSihggbN4130_assertion description "[A number of corroborating methodologies, including in situ hybridization, e-Northern analysis using ORF EST (ORESTES) and Unigene EST abundance analysis, immunoblot and immunofluorescence analysis of breast tumor cell lines, and immunohistochemistry, confirmed the microarray findings.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322772.RABJntw9hkXc8B26gC38kTf4tzPJbYOC6gDAYSihggbN4130_provenance.
- NP322772.RABJntw9hkXc8B26gC38kTf4tzPJbYOC6gDAYSihggbN4130_assertion evidence source_evidence_literature NP322772.RABJntw9hkXc8B26gC38kTf4tzPJbYOC6gDAYSihggbN4130_provenance.
- NP322772.RABJntw9hkXc8B26gC38kTf4tzPJbYOC6gDAYSihggbN4130_assertion SIO_000772 16043716 NP322772.RABJntw9hkXc8B26gC38kTf4tzPJbYOC6gDAYSihggbN4130_provenance.
- NP322772.RABJntw9hkXc8B26gC38kTf4tzPJbYOC6gDAYSihggbN4130_assertion wasDerivedFrom befree-20150227 NP322772.RABJntw9hkXc8B26gC38kTf4tzPJbYOC6gDAYSihggbN4130_provenance.
- NP322772.RABJntw9hkXc8B26gC38kTf4tzPJbYOC6gDAYSihggbN4130_assertion wasGeneratedBy ECO_0000203 NP322772.RABJntw9hkXc8B26gC38kTf4tzPJbYOC6gDAYSihggbN4130_provenance.